FDA Ophthalmic Device Panel Advocates Bausch + Lomb Intraocular Lens

The Bausch + Lomb Trulign toric accommodating posterior chamber ocular lens has received premarket approval from the Ophthalmic Devices Panel of the FDA, according to a Medscape report.

Advertisement

On April 8, 10 of the 12 panel members voted that the intraocular lens was safe, effective and had benefits that outweighed its risks.

More Articles on Ophthalmology:

Researchers Find Possible Prevention of Retinal Detachment Side Effect
FDA Approves PROLENSA from Bausch + Lomb
Bausch + Lomb VICTUS Femtosecond Laser Earns CE Mark

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.